Seeking Alpha

Alnylam Pharmaceuticals (ALNY +4.8%) is higher this morning after reaching a settlement with...

Alnylam Pharmaceuticals (ALNY +4.8%) is higher this morning after reaching a settlement with Tekmira Pharmaceuticals (TKMR +19.3%) resolving all litigation issues between the companies. It also signed a new licensing agreement that restructures the relationship and provides clarity on all intellectual property and licensing issues. As a result, TKMR will receive $65M within 10 days and is eligible to receive an additional $10M in near-term milestone payments in 2013. (Conference Call Webcast Replay)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs